Theragent Inc., a comprehensive CDMO focused on advancing next-generation cell- and tissue-based therapies, has announced a partnership with Pluristyx, Inc., an early stage, privately...
Lantern Pharma Inc., a leading artificial intelligence (AI) oncology drug discovery and development company, announced a strategic AI-driven collaboration with French biotechnology company, Oregon...
Araceli Biosciences, experts in cell-based screening and analysis technologies announced that their Board of Directors has appointed Matthew (Matt) Beaudet as the company's new...
Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, announced the availability of Evercode™ BCR and the expansion of its...
Here is Read Magazine’s Weekly Roundup of the top news from global markets. In this fast-paced world, breaking down information helps readers grasp the...
